Stew Peters Episode on Spontaneous Abortion After Vaxxination

By Steve Kirsch

Jessica Rose’s research based on VAERS and DMED data shows a huge increase. Published technical papers say there is no effect. Who do you think is telling the truth?

I was on Stew Peters show earlier today (Rumble) talking about miscarriages.

400,000 Vaxx Abortions: Military Data Confirms 300% Increase In Miscarriages

 

We know that any substance consumed by pregnant women can be deadly to the baby. Big pharma ads don’t let us forget it, nor do the thousands of mothers working tirelessly in social media groups to inform each other about the things that can kill their kids.

When it comes to Dr. Fauci’s unholy clot shot, even the New York Times has admitted that vaccinated women are experiencing a chaotic menstrual cycle, and post-menopausal women have even started their periods again.

The original study I was referring to in the video interview is here. That was the data that the CDC had at the time they recommended pregnant women get jabbed. In short, they had very incomplete data. What the CDC did was unethical.

In the interview, I discuss what the DMED data and VAERS data said. For more on this, see my article on spontaneous abortions after vaccination.

 

COVID vaccines and pregnancy: >416,186 spontaneous abortions due to the vaccine

A new analysis by Dr. Jessica Rose estimates the number of spontaneous abortions caused by the COVID vaccines. It’s over 416,186 to date. I’ve notified the CDC, but I don’t expect to hear back.

Here’s Jessica’s article on spontaneous abortions (SA) post-vaccination.

Basically, using rate data recently released from the Department of Defense, she computes an under reporting factor (URF) for VAERS for spontaneous abortions is 118. Since there are 3,527 reports of SA in the US in 2021, this represents 416,186 actual events. But a small number of those were not caused by the vaccine, somewhere around 1%.

Using the DMED data, the five-year average was 1,499 codes for miscarriages per year. During the first 10 months of 2021, it was 4,182. So that’s 3.4X the baseline rate (when extended to an annual rate).

The sanity checks both pass

Now, let’s do a “ballpark” sanity check on the VAERS numbers. In DMED, SAs after vax were 3.4X the baseline rate. In the US there are around 750K miscarriages per year. So if we multiply that by 3.4 and assume that 20% of the women were vaccinated within the first or second trimester (where the effect is largest), we get 510K which is not far from our VAERS estimate of 416K.

Our second sanity check is the URF of 118. We’ve determined before a URF for the most serious adverse events at 41. For less serious events, especially ones that nobody thinks is caused by the vaccine and is often many months from vaccination is easily 3X higher. So that makes sense as well.

I’ve notified the CDC of this, but I don’t expect them to change their policy of recommending the vaccine to pregnant women.

Also note that pregnant women were NOT included in the vaccine trials. It is medical malpractice to recommend the vaccines to pregnant women. The CDC repeatedly declared them safe for pregnant women without complete data.

I don’t expect the mainstream media to question the CDC on this at all. I’m sure they will all ignore it.

Supporting evidence in VAERS

Plenty of evidence in VAERS showing the vaccine messes with a woman’s reproductive organs just as we predicted from the biodistribution data (which targeted the ovaries).

You can view both the biodistribution data and the menstrual adverse effect data in this VAERS analysis article I wrote in November, 2022.

For others, may I suggest if you disagree with this that you show us an error in the data or methodology?

 

Note that other papers that came out recently do not find a signal.

Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion

Pregnant persons are at risk for severe coronavirus disease 2019 (Covid-19), and infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during pregnancy is associated with increased risks of preterm birth and other adverse maternal and neonatal outcomes. Although spontaneous abortion (pregnancy loss occurring at less than 20 weeks of gestation) is a common pregnancy outcome affecting 11 to 22% of recognized pregnancies (see Table S1 in the Supplementary Appendix, available with the full text of this letter at NEJM.org), data to inform estimates of the risk of spontaneous abortion after receipt of an mRNA Covid-19 vaccine either before conception (30 days before the first day of the last menstrual period through 14 days after) or during pregnancy are limited.

We analyzed data from the Centers for Disease Control and Prevention (CDC) v-safe Covid-19 vaccine pregnancy registry to determine the cumulative risk of spontaneous abortion from 6 to less than 20 weeks of gestation. Participants with a singleton pregnancy who had received at least one dose of an mRNA Covid-19 vaccine either before conception or before 20 weeks of gestation and who did not have a pregnancy loss before 6 weeks of gestation were included in this analysis. Inclusion of pregnant participants at 6 weeks of gestation is consistent with literature estimating the risk of spontaneous abortion in the general population. Life table methods were used to calculate the cumulative risk of spontaneous abortion according to gestational week, with appropriate left truncation (i.e., with adjustment for gestational age at entry); data were right-censored at the time of the most recent contact for participants with ongoing pregnancies who were not contacted at 20 weeks of gestation or later and at the time of the outcome for participants who reported pregnancy outcomes other than spontaneous abortion (induced abortions or ectopic or molar pregnancies) before 20 weeks of gestation. The cumulative risk of spontaneous abortion was also age-standardized with the use of data on the risk of spontaneous abortion according to maternal age group. We conducted a sensitivity analysis to estimate the maximum possible risk of spontaneous abortion, using an extreme assumption that all participants whose most recent contact was during the first trimester (i.e., at less than 14 weeks of gestation) and whom we were unable to reach during the second trimester experienced a spontaneous abortion immediately after the most recent contact (see the Supplementary Appendix for details).

Table 1. Risk of Spontaneous Abortion among Participants in the v-safe Covid-19 Vaccine Pregnancy Registry, December 14, 2020, through July 19, 2021.

A total of 2456 participants who were enrolled in the CDC v-safe Covid-19 pregnancy registry met the inclusion criteria for this study; 2022 participants reported ongoing pregnancies at 20 weeks of gestation, 165 participants reported a spontaneous abortion (154 participants before 14 weeks of gestation), 65 participants with most recent contact during the first trimester could not be reached for second trimester follow-up, 188 participants completed second trimester follow-up before 20 weeks of gestation, and 16 participants reported another pregnancy outcome before 20 weeks (induced abortion or ectopic or molar pregnancy) (Fig. S1). Most participants were 30 years of age or older (77.3%), were non-Hispanic White (78.3%), and worked as health care personnel (88.8%). Slightly more than half the participants (52.7%) had received the BNT162b2 vaccine (Pfizer–BioNTech) (Table S2). The cumulative risk of spontaneous abortion from 6 to less than 20 weeks of gestation was 14.1% (95% confidence interval [CI], 12.1 to 16.1) in the primary analysis (Table 1) and 12.8% (95% CI, 10.8 to 14.8) in an analysis using direct maternal age–standardization to the reference population. The cumulative risk of spontaneous abortion increased with maternal age (Table S3). In the sensitivity analysis, under the extreme assumption that all 65 participants with most recent contact during the first trimester had a spontaneous abortion, the cumulative risk of spontaneous abortion from 6 to less than 20 weeks of gestation was 18.8% (95% CI, 16.6 to 20.9); after age standardization, the cumulative risk was 18.5% (95% CI, 16.1 to 20.8).

Figure 1. Cumulative Risk of Spontaneous Abortion in the v-safe Covid-19 Vaccine Pregnancy Registry and in Two Historical Cohorts.

As compared with data from two historical cohorts that represent the lower and upper ranges of spontaneous-abortion risk, the cumulative risks of spontaneous abortion from our primary and sensitivity analyses were within the expected risk range (Figure 1). Limitations of our study include the lack of a control group of unvaccinated pregnant persons, the homogeneity of the participants in terms of racial and ethnic groups and occupation, the voluntary enrollment of the population, and the use of data reported by the participants themselves, including some data collected retrospectively. Nonetheless, our findings suggest that the risk of spontaneous abortion after mRNA Covid-19 vaccination either before conception or during pregnancy is consistent with the expected risk of spontaneous abortion; these findings add to the accumulating evidence about the safety of mRNA Covid-19 vaccination in pregnancy.⁵

Lauren H. Zauche, Ph.D., M.S.N.
Bailey Wallace, M.P.H.
Ashley N. Smoots, M.P.H.
Christine K. Olson, M.D., M.P.H.
Titilope Oduyebo, M.D., M.P.H.
Shin Y. Kim, M.P.H.
Emily E. Petersen, M.D.
Jun Ju, M.S.
Jennifer Beauregard, Ph.D., M.P.H.
Centers for Disease Control and Prevention (CDC), Atlanta, GA

Allen J. Wilcox, M.D., Ph.D.
National Institutes of Health, Durham, NC

Charles E. Rose, Ph.D.
Dana M. Meaney-Delman, M.D., M.P.H.
Sascha R. Ellington, Ph.D., M.S.P.H.
CDC, Atlanta, GA

for the CDC v-safe Covid-19 Pregnancy Registry Team

Disclosure forms provided by the authors are available with the full text of this letter at NEJM.org.

The findings and conclusions in this letter are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention (CDC). Mention of a product or company name is for identification purposes only and does not constitute endorsement by the CDC or the Food and Drug Administration. The authors do not have any material conflicts of interest.

We can’t both be right so you will have to decide who you want to believe.

 

If you are having trouble deciding, read this article by Colleen Huber.

COVID vaccines may rival or exceed ‘the morning-after pill’ in abortion efficacy

I compare the abortion efficacy rate of the COVID vaccine with the morning-after pill, RU-486, aka mifepristone.  The V-Safe Surveillance System was developed by the CDC V-Safe COVID-19 Pregnancy Registry Team for monitoring of the COVID vaccination program in pregnancy.  In their Preliminary Findings, there were 827 pregnant women who received at least one dose of either the Pfizer or Moderna COVID vaccine, and who then had “a completed pregnancy.”  A completed pregnancy was defined to include live-born infant, spontaneous abortion (miscarriage), still birth, induced abortion or ectopic pregnancy.

Their reported results were as follows for 827 completed pregnancies following COVID vaccination:

* 96 of the 104 pregnant women who had spontaneous abortions were vaccinated before 13 weeks gestation.

Of those 116 women vaccinated during the first and second trimesters and then had a completed pregnancy of either live birth, spontaneous abortion or stillbirth, there were 104 miscarriages (spontaneous abortion).  This is a miscarriage rate of 89.66%.

The morning-after abortion pill, mifepristone, has a reported efficacy rate of 80% to 90%. Mifepristone has a black box warning. Therefore, because the two drugs demonstrate comparable abortion potential, they should both carry black box warnings, fully informed and uncoerced consent, and should be strictly avoided by the general population. These data may be corrected up or down by following COVID-vaccinated pregnant women till the end of 40 weeks of expected duration of gestation for all of the pregnant women included in the study.